developing therapeutic cancer vaccines

Company

Profile
Business strategy
Management
Scientific advisory board
Investors
Partners

Investors

Hanzepoort BV

Kennis Conversie Fonds BV / RUG Houdstermaatschappij BV

Stichting G.J. Smid Fonds

VenGen Participaties BV